369 related articles for article (PubMed ID: 33570949)
21. From anti-Parkinson's drug rasagiline to novel multitarget iron chelators with acetylcholinesterase and monoamine oxidase inhibitory and neuroprotective properties for Alzheimer's disease.
Zheng H; Amit T; Bar-Am O; Fridkin M; Youdim MB; Mandel SA
J Alzheimers Dis; 2012; 30(1):1-16. PubMed ID: 22387411
[TBL] [Abstract][Full Text] [Related]
22. Zn(II)- and Cu(II)-induced non-fibrillar aggregates of amyloid-beta (1-42) peptide are transformed to amyloid fibrils, both spontaneously and under the influence of metal chelators.
Tõugu V; Karafin A; Zovo K; Chung RS; Howells C; West AK; Palumaa P
J Neurochem; 2009 Sep; 110(6):1784-95. PubMed ID: 19619132
[TBL] [Abstract][Full Text] [Related]
23. Antioxidants as a potential therapy against age-related neurodegenerative diseases: amyloid Beta toxicity and Alzheimer's disease.
Hajieva P; Behl C
Curr Pharm Des; 2006; 12(6):699-704. PubMed ID: 16472160
[TBL] [Abstract][Full Text] [Related]
24. Preparation of Tetradentate Copper Chelators as Potential Anti-Alzheimer Agents.
Zhang W; Huang D; Huang M; Huang J; Wang D; Liu X; Nguyen M; Vendier L; Mazères S; Robert A; Liu Y; Meunier B
ChemMedChem; 2018 Apr; 13(7):684-704. PubMed ID: 29420864
[TBL] [Abstract][Full Text] [Related]
25. The Pivotal Role of Copper in Neurodegeneration: A New Strategy for the Therapy of Neurodegenerative Disorders.
Giampietro R; Spinelli F; Contino M; Colabufo NA
Mol Pharm; 2018 Mar; 15(3):808-820. PubMed ID: 29323501
[TBL] [Abstract][Full Text] [Related]
26. Effects of clioquinol on metal-triggered amyloid-beta aggregation revisited.
Mancino AM; Hindo SS; Kochi A; Lim MH
Inorg Chem; 2009 Oct; 48(20):9596-8. PubMed ID: 19817493
[TBL] [Abstract][Full Text] [Related]
27. Amyloid-beta metal interaction and metal chelation.
Cuajungco MP; Frederickson CJ; Bush AI
Subcell Biochem; 2005; 38():235-54. PubMed ID: 15709482
[TBL] [Abstract][Full Text] [Related]
28. Histidine-rich branched peptides as Cu(II) and Zn(II) chelators with potential therapeutic application in Alzheimer's disease.
Lakatos A; Gyurcsik B; Nagy NV; Csendes Z; Wéber E; Fülöp L; Kiss T
Dalton Trans; 2012 Feb; 41(6):1713-26. PubMed ID: 22159144
[TBL] [Abstract][Full Text] [Related]
29. Gold nanoparticle-capped mesoporous silica-based H
Yang L; Yin T; Liu Y; Sun J; Zhou Y; Liu J
Acta Biomater; 2016 Dec; 46():177-190. PubMed ID: 27619837
[TBL] [Abstract][Full Text] [Related]
30. Characterization of new specific copper chelators as potential drugs for the treatment of Alzheimer's disease.
Nguyen M; Robert A; Sournia-Saquet A; Vendier L; Meunier B
Chemistry; 2014 May; 20(22):6771-85. PubMed ID: 24797103
[TBL] [Abstract][Full Text] [Related]
31. Chelating agents for neurodegenerative diseases.
Ward RJ; Dexter DT; Crichton RR
Curr Med Chem; 2012; 19(17):2760-72. PubMed ID: 22489724
[TBL] [Abstract][Full Text] [Related]
32. Repurposing of Copper(II)-chelating Drugs for the Treatment of Neurodegenerative Diseases.
Lanza V; Milardi D; Di Natale G; Pappalardo G
Curr Med Chem; 2018 Feb; 25(4):525-539. PubMed ID: 28521682
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, physical-chemical characterisation and biological evaluation of novel 2-amido-3-hydroxypyridin-4(1H)-ones: Iron chelators with the potential for treating Alzheimer's disease.
Gaeta A; Molina-Holgado F; Kong XL; Salvage S; Fakih S; Francis PT; Williams RJ; Hider RC
Bioorg Med Chem; 2011 Feb; 19(3):1285-97. PubMed ID: 21236688
[TBL] [Abstract][Full Text] [Related]
34. Mechanistic comparison of current pharmacological treatments and novel phytochemicals to target amyloid peptides in Alzheimer's and neurodegenerative diseases.
Ayyalasomayajula N; Suresh C
Nutr Neurosci; 2018 Dec; 21(10):682-694. PubMed ID: 28683598
[TBL] [Abstract][Full Text] [Related]
35. Effect of metal chelators on the aggregation of beta-amyloid peptides in the presence of copper and iron.
Tahmasebinia F; Emadi S
Biometals; 2017 Apr; 30(2):285-293. PubMed ID: 28281098
[TBL] [Abstract][Full Text] [Related]
36. Histidine-Rich Oligopeptides To Lessen Copper-Mediated Amyloid-β Toxicity.
Caballero AB; Terol-Ordaz L; Espargaró A; Vázquez G; Nicolás E; Sabaté R; Gamez P
Chemistry; 2016 May; 22(21):7268-80. PubMed ID: 27071336
[TBL] [Abstract][Full Text] [Related]
37. Effects of cyclen and cyclam on zinc(II)- and copper(II)-induced amyloid beta-peptide aggregation and neurotoxicity.
Chen T; Wang X; He Y; Zhang C; Wu Z; Liao K; Wang J; Guo Z
Inorg Chem; 2009 Jul; 48(13):5801-9. PubMed ID: 19496588
[TBL] [Abstract][Full Text] [Related]
38. The redox chemistry of the Alzheimer's disease amyloid beta peptide.
Smith DG; Cappai R; Barnham KJ
Biochim Biophys Acta; 2007 Aug; 1768(8):1976-90. PubMed ID: 17433250
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and evaluation of peptidic metal chelators for neuroprotection in neurodegenerative diseases.
Zheng H; Youdim MB; Weiner LM; Fridkin M
J Pept Res; 2005 Oct; 66(4):190-203. PubMed ID: 16138857
[TBL] [Abstract][Full Text] [Related]
40. Werner coordination chemistry and neurodegeneration.
Telpoukhovskaia MA; Orvig C
Chem Soc Rev; 2013 Feb; 42(4):1836-46. PubMed ID: 22952002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
